Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Anavex Lf SC (AVXL)

Anavex Lf SC (AVXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

AVXL : 10.55 (-6.06%)
Anavex Life Sciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

AVXL : 10.55 (-6.06%)
Short-Squeeze Target Anavex Life Sciences Gains Traction

Anavex Life Sciences stock market is set up for a short squeeze that could begin in early 2025 and increase the price by 400% or more.

AVXL : 10.55 (-6.06%)
Anavex Life Sciences: Fiscal Q4 Earnings Snapshot

Anavex Life Sciences: Fiscal Q4 Earnings Snapshot

AVXL : 10.55 (-6.06%)
Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update

AVXL : 10.55 (-6.06%)
Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease

AVXL : 10.55 (-6.06%)
Anavex Life Sciences Corp. to Announce Fiscal Year 2024 Financial Results on December 23, 2024

Anavex Life Sciences Corp. will announce fiscal year results on December 23, 2024, with a conference call to follow.Quiver AI SummaryAnavex Life Sciences Corp. announced that it will release its financial...

AVXL : 10.55 (-6.06%)
Anavex Life Sciences to Announce Fiscal 2024 Fourth Quarter Financial Results on Monday, December 23, 2024

AVXL : 10.55 (-6.06%)
Anavex Life Sciences to Present Long-Term Data from Phase IIb/III ATTENTION-AD Trial at J.P. Morgan 2025 Healthcare Conference

Anavex will present long-term ATTENTION-AD trial data at the J.P. Morgan 2025 Healthcare Conference in January.Quiver AI SummaryAnavex Life Sciences Corp. is set to present topline long-term data from...

AVXL : 10.55 (-6.06%)

Barchart Exclusives

3 Nuclear Power Stocks to Buy in 2025 for an AI Gold Rush
Artificial intelligence has forced data center operators to revisit nuclear power for critical energy supplies. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar